IE35535L - Adenosine-5'-carboxylic acid derivatives - Google Patents

Adenosine-5'-carboxylic acid derivatives

Info

Publication number
IE35535L
IE35535L IE710884A IE88471A IE35535L IE 35535 L IE35535 L IE 35535L IE 710884 A IE710884 A IE 710884A IE 88471 A IE88471 A IE 88471A IE 35535 L IE35535 L IE 35535L
Authority
IE
Ireland
Prior art keywords
formula
carboxylic acid
adenosine
acid addition
radical
Prior art date
Application number
IE710884A
Other versions
IE35535B1 (en
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IE35535L publication Critical patent/IE35535L/en
Publication of IE35535B1 publication Critical patent/IE35535B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Abstract

1295228 Adenosine derivatives BOEHRINGER MANNHEIM GmbH 8 July 1971 [14 July 1970] 32182/71 Heading C2C Novel compounds of Formula I (in which each of R 1 and R 2 is H, OH, NH 2 , C 1-6 alkyl, C 2-6 alkenyl, optionally N-alkylated C 1-6 aminoalkyl, cycloalkyl, hydroxyalkyl or piperidino or R 1 and R 2 together represent a C 4-7 alkylene radical which can be interrupted by an oxygen or sulphur atom or an imino, alkylimino or arylimino radical and Z represents two hydrogen atoms or a C 2-6 alkylidene radical) and pharmacologically compatible acid addition salts thereof, are prepared by reacting a reactive derivative of a carboxylic acid of the Formula II with a compound of formula R 1 -NH-R 2 and optionally converting the product obtained into a pharmacologically compatible acid addition salt. 2<SP>1</SP>,3<SP>1</SP> - o - Isopropylidene - adenosine - 5<SP>1</SP> - carboxylic acid chloride is prepared by reacting the corresponding acid with thionyl chloride. Pharmaceutical compositions for oral or parenteral administration, comprise a compound of Formula I or a pharmacologically acceptable acid addition salt thereof, together with a pharmaceutical carrier or diluent. The active compounds exhibit a strong circulatory activity. [GB1295228A]
IE884/71A 1970-07-14 1971-07-13 Adenosine-5'-carboxylic acid derivatives IE35535B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19702034785 DE2034785A1 (en) 1970-07-14 1970-07-14 Adenosine 5 carboxylic acid derivatives

Publications (2)

Publication Number Publication Date
IE35535L true IE35535L (en) 1972-01-14
IE35535B1 IE35535B1 (en) 1976-03-18

Family

ID=5776675

Family Applications (1)

Application Number Title Priority Date Filing Date
IE884/71A IE35535B1 (en) 1970-07-14 1971-07-13 Adenosine-5'-carboxylic acid derivatives

Country Status (16)

Country Link
AT (1) AT306253B (en)
AU (1) AU449293B2 (en)
CA (1) CA1077931A (en)
CH (1) CH556345A (en)
DE (1) DE2034785A1 (en)
ES (1) ES393022A1 (en)
FI (1) FI54316C (en)
FR (1) FR2100901B1 (en)
GB (1) GB1295228A (en)
HU (1) HU162216B (en)
IE (1) IE35535B1 (en)
IL (1) IL37280A (en)
NL (1) NL7109584A (en)
SE (1) SE378604B (en)
YU (1) YU34533B (en)
ZA (1) ZA714483B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1082695A (en) * 1972-04-10 1980-07-29 Francis E. Fischer Process for preparing adenosine-5'-carboxamides
US3853846A (en) * 1973-02-12 1974-12-10 Abbott Lab INOSINE-5 -Carboxylates
US3852268A (en) * 1973-02-12 1974-12-03 Abbott Lab Inosine-5 -carboxylic acid amides
US3855206A (en) * 1973-04-11 1974-12-17 Abbott Lab Adenosine-5{40 -carbohydroxamic esters
US3966917A (en) * 1974-07-30 1976-06-29 Abbott Laboratories Platelet aggregation inhibitors
AT350735B (en) * 1976-08-06 1979-06-11 Hoffmann La Roche METHOD FOR PRODUCING NEW RIBO-FURANOSYL IMIDAZOLE DERIVATIVES
US4479942A (en) * 1981-08-10 1984-10-30 Fujisawa Pharmaceutical Co., Ltd. Tetrahydrofurnancarboxylic acid derivatives, processes for preparation thereof and pharmaceutical compositions thereof
US5278150A (en) * 1992-04-24 1994-01-11 Whitby Research, Inc. 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
YU44900A (en) 1998-01-31 2003-01-31 Glaxo Group Limited 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
PE20060272A1 (en) 2004-05-24 2006-05-22 Glaxo Group Ltd (2R, 3R, 4S, 5R, 2'R, 3'R, 4'S, 5'S) -2.2 '- {TRANS-1,4-CYCLOHEXANODIYLBIS- [IMINO (2 - {[2- (1-METHYL- 1H-IMIDAZOL-4-IL) ETHYL] AMINO} -9H-PURIN-6,9-DIYL)]} BIS [5- (2-ETHYL-2H-TETRAZOLE-5-IL) TETRAHYDRO-3,4-FURANODIOL] AS AN A2A AGONIST
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
SU385448A3 (en) 1973-05-29
FR2100901A1 (en) 1972-03-24
ES393022A1 (en) 1973-08-01
DE2034785A1 (en) 1972-01-20
YU183371A (en) 1979-02-28
GB1295228A (en) 1972-11-08
FR2100901B1 (en) 1974-11-15
FI54316B (en) 1978-07-31
HU162216B (en) 1973-01-29
FI54316C (en) 1978-11-10
AU449293B2 (en) 1974-06-06
IE35535B1 (en) 1976-03-18
SE378604B (en) 1975-09-08
AU3115971A (en) 1973-01-18
ZA714483B (en) 1972-04-26
AT306253B (en) 1973-04-10
NL7109584A (en) 1972-01-18
IL37280A0 (en) 1971-10-20
CH556345A (en) 1974-11-29
IL37280A (en) 1974-03-14
CA1077931A (en) 1980-05-20
YU34533B (en) 1979-09-10

Similar Documents

Publication Publication Date Title
ES8607297A1 (en) Thiazolidine derivatives, their preparation and compositions containing them.
IE35535L (en) Adenosine-5&#39;-carboxylic acid derivatives
GB1489609A (en) 1-substituted 1h-tetrazole-5-thiols and the preparation thereof
GB1279895A (en) O-acyl-lysergols and process for preparing them
ES8302001A1 (en) Cephalosporin derivatives, a process for their preparation and compositions containing them.
DE3567650D1 (en) 1,5-benzothiazephine derivatives, processes for preparing the same and pharmaceutical compositions
ES8602837A1 (en) 4&#34;-Epi erythromycin A and derivatives thereof as useful antibacterial agents.
DE3567651D1 (en) Novel 1,5-benzothiazepine derivative, processes for preparing the same and pharmaceutical compositions
GB1298112A (en) Phenyl acetyl guanidine derivatives
IL85725A (en) Imidazole derivatives,their manufacture and pharmaceutical compositions containing them
GB1461874A (en) 2-1-piperazinyl-thiazole derivatives
ES8607317A1 (en) Cephalosporin ester derivatives, their production and use.
GB1500063A (en) Indolinone and fluorenone derivatives
ES8401761A1 (en) 1-(3,4,5-Trimethoxycinnamoyl)-4-aminocarbonylethyl-substituted piperazine derivatives and a process for the preparation thereof.
GB1390402A (en) Substituted imidazolecarboxamides
GB1207930A (en) Azacycloaliphatic compounds, process for their manufacture and compositions containing them
GB1382787A (en) Aryl-piperazine derivatives of adenine
GB1436502A (en) Amide derivatives of 3-benzoylphenyl-alkanoic acids
GB8515212D0 (en) Thiazolidine derivatives
GR860045B (en) Novel piperazine derivatives processes for production thereof and pharmaceutical compositions comprising said compounds as active ingredient
GB1245155A (en) NOVEL 5-SUBSTITUTED-gamma-CARBOLINE DERIVATIVES AND THE SALTS THEREOF
GB1527941A (en) 1-(3-phenylpropyl)-4-(beta-alkoxyacryloyl)piperazine derivatives
GB1418831A (en) Reserpine derivatives
GB1339010A (en) Tetrazolyl-anthraquinone derivatives
HU895651D0 (en) Process for the preparation of substituted 3-amino-nonimine derivatives and pharmaceutical compositions containing said compounds